Evaluating seizures in patients with brain tumors
Official title: Tumor Related Epilepsy
Run by National Institutes of Health Clinical Center (CC) · NCT02639325 · Data updated 2026-11-12
This study looks at how brain tumors that cause seizures affect people aged 8 and older, and whether surgery can help reduce those seizures and improve thinking skills.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | January 26, 2016 |
| Main results expected | July 1, 2032 |
| Study ends | July 1, 2032 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT02639325 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 8 and older with a confirmed diagnosis of a brain tumor and associated seizures.
✕Probably not a fit
Patients who do not have a brain tumor or those whose seizures are not related to a brain tumor may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on individuals aged 8 and older who have brain tumors associated with seizures, known as tumor-related epilepsy. The research aims to evaluate the natural history of this condition and the impact of surgical treatment on seizure outcomes. Participants will undergo a thorough medical evaluation, including neurological exams and cognitive assessments, to gather data on their condition before and after surgery. The study also seeks to explore the relationship between tumor characteristics, surgical resection, and changes in seizure activity and cognitive function.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced seizure frequency for patients with brain tumors.
How similar studies have gone: Other studies have shown promising results in surgical interventions for tumor-related epilepsy, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: To be eligible for entry into the study, a candidate must meet all the following criteria: * Be 8 years of age or older. * Have solitary primary or recurrent brain tumor with associated seizures. Brain tumor may be diagnosed radiologically. Associated seizures are defined as those with activity starting within three months of radiologic diagnosis of the primary or recurrent tumor. In cases when the timing of seizure activity is unclear with respect to the timing of diagnosis, seizures will be considered associated with the tumor if seizure semiology is consistent with that location. Ongoing seizures are not required. Patients can be included if they have had a single previous seizure. Patients who have not experienced seizures after institution of anti-convulsant therapy are not excluded. EXCLUSION CRITERIA: Candidates will be excluded if they: -At the time of enrollment, lack consent capacity due to cognitive impairment that would make them incapable of understanding the explanation of the procedures in this study. Cognitive capacity to consent will be determined at the time of enrollment. Patients with mental disorders or those patients who are cognitively impaired yet still retain consent capacity will not be excluded. Children may be enrolled if there is a parent or guardian able to consent on their behalf.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Kareem A Zaghloul, M.D. — National Institute of Neurological Disorders and Stroke (NINDS)
- Study coordinator: Gretchen C Scott, R.N.
- Email: SNBrecruiting@nih.gov
- Phone: (301) 496-2921
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.